Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free vs preserved dexamethasone and diclofenac eye drops after cataract surgery
2017-004127-79Phase 4Active
- Sponsor
- UZ Leuven
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone, Voltaren Ophtha CD and diclofenac in Postoperative ocular inflammation, dry eye syndrome (DED) and macular edema (2 arms), sponsored by UZ Leuven. Primary endpoint: Change in aqueous flare. Started Jan 2018; status: active.
02
Drugs
dexamethasoneVoltaren Ophtha CDdiclofenac
03
Conditions
Postoperative ocular inflammationdry eye syndrome (DED)macular edema
Beyond the preview
Go deeper on 2017-004127-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004127-79.